We performed a descriptive case–control study in which the different outcomes for sporadic, MEN1- and MEN2A-related primary hyperparathyroidism were assessed and possible contributing confounding factors were analyzed. This evidence concerns the gene MEN1 and primary hyperparathyroidism.